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Abstract
Background: Regarding regenerative medicine for diabetes, accessible sources of Mesenchymal Stem Cells (MSCs) for
induction of insular beta cell differentiation may be as important as mastering the differentiation process itself.
Methodology/Principal Findings: In the present work, stem cells from pancreatic islets (human islet-mesenchymal stem
cells, HI-MSCs) and from human bone marrow (bone marrow mesenchymal stem cells, BM-MSCs) were cultured in custom-
made serum-free medium, using suitable conditions in order to induce differentiation into Islet-like Cells (ILCs). HI-MSCs and
BM-MSCs were positive for the MSC markers CD105, CD73, CD90, CD29. Following this induction, HI-MSC and BM-MSC
formed evident islet-like structures in the culture flasks. To investigate functional modifications after induction to ILCs,
ultrastructural analysis and immunofluorescence were performed. PDX1 (pancreatic duodenal homeobox gene-1), insulin, C
peptide and Glut-2 were detected in HI-ILCs whereas BM-ILCs only expressed Glut-2 and insulin. Insulin was also detected in
the culture medium following glucose stimulation, confirming an initial differentiation that resulted in glucose-sensitive
endocrine secretion. In order to identify proteins that were modified following differentiation from basal MSC (HI-MSCs and
BM-MSCs) to their HI-ILCs and BM-ILCs counterparts, proteomic analysis was performed. Three new proteins (APOA1, ATL2
and SODM) were present in both ILC types, while other detected proteins were verified to be unique to the single individual
differentiated cells lines. Hierarchical analysis underscored the limited similarities between HI-MSCs and BM-MSCs after
induction of differentiation, and the persistence of relevant differences related to cells of different origin.
Conclusions/Significance: Proteomic analysis highlighted differences in the MSCs according to site of origin, reflecting
spontaneous differentiation and commitment. A more detailed understanding of protein assets may provide insights
required to master the differentiation process of HI-MSCs to functional beta cells based only upon culture conditioning.
These findings may open new strategies for the clinical use of BM-MSCs in diabetes.
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Introduction
Type I diabetes is an immunologically-mediated disease with a
genetic predisposition and results in the destruction of b-cells in
pancreatic islets. Current therapy is based upon the long-life
parenteral injection of insulin.
Although other therapeutic approaches such as pancreas or
pancreatic islet transplantation may appear attractive, they are
hampered by several difficulties (i.e. shortage of solid organs
donors, immunosuppression, to avoid immunological rejection
and long-lasting complications). Therefore transplantation is
seldom used in clinical practice [1,2].
Adult stem cells and their manipulation may open new
perspectives for a radical therapeutic approach to type I diabetes
[3].
Stem cell (SC) plasticity and their capability of being
manipulated to induce differentiation, may allow the in vitro
expansion of insulin-producing cells suitable for in vivo transplan-
tation. Therefore, immune-mediated rejection could be avoided if
insulin-secreting cells were obtained from the patient’s own stem
cells. A key issue for future clinical use of conditioned SC is
represented by the site of origin that should be easily accessible
and allow the harvesting of a stem cell population sufficient for in
vitro manipulations and subsequent in vivo engrafting.
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28175To date, several studies have reported experimental data on
differentiation, from stem cells of varying origins, to islet-like cells
(ILCs) [4].
Nevertheless, the process for induction of differentiation is not
completely understood and may be influenced by different culture
conditioning [3].
With the present study we report our experience on culturing
mesenchymal stem cells (MSCs) derived from either pancreatic
islets (HI-MSCs) or bone marrow aspirate (BM-MSCs), in a
serum-free culture medium of our formulation, resulting in the
production of insulin.
It has been demonstrated the presence of human islet-derived
precursor cells that exhibit many characteristics of MSC [5] and
that could be considered a source of beta-cells ex vivo production.
Despite the presence of this resident MSC population in human
islets, bone marrow may represent a potential source of MSC
that is accessible for SC harvesting, as the hematological
widespread transplantation practice demonstrate, especially if
compared to pancreatic islets that are difficult to sample and,
more relevant, seriously damaged or destroyed in diabetic
patients.
We applied proteomic techniques to evaluate whether variations
in protein expression in expanded and differentiated HI-MSCs
and BM-MSCs are inherent to SC origin or whether they are
influenced by the conditioning process.
Proteomic profiling of human pancreatic islet-cells has been
reported, [6,7] with the identification of 66 different proteins,
serving as a reference map of human islet cell populations. These
data were however at variance with the reported proteomic data
on islet cells of murine and rat origin [8,9].
A wealth of data, including proteomic studies, using cultured rat
insulinoma cells were put forward, and were focused on selected
insulin-secreting clones [10]. Sophisticated proteomic data on
mouse and rat models of type II diabetes have been reported in the
literature [11,12].
In addition, a report of the proteomic profile of ovine BM-
MSCs has been recently described, including comparisons with
MSCs from other tissues of origin [13]. Nevertheless, detailed data
comparing human MSCs of different origin have yet to be
described, and no proteomic data have been reported on HI-
MSCs. The comparison of the proteomic assets of HI and BM-
MSCs may unravel similarities and differences correlated to the
differentiation process, and it might provide new insights into the
conditioning protocols required in order to achieve a stable and
robust secretion of insulin.
Results
Characterization of BM- and HI-MSCs
BM-MSC and HI-MSC preparations satisfied the minimal
criteria fixed by the International Society for Cellular Therapy to
define a population as mesenchymal stromal cells [14,15].
Therefore, BM and HI-MSCs were plastic-adherent when
maintained in expansion conditions; BM- and HI-MSC prepara-
tions expressed CD105, CD73, CD90 and CD29 (Figure 1 A and
B), and they did not express hematopoietic markers, like CD45,
CD14 and CD34.
Figure 1. Characterization of BM and HI-MSCs. Representative FACS analyses shows that BM and HI-MSCs were positive for surface marker
characterization of MSCs (CD105, CD73, CD90, CD29), and were negative for specific hematopoietic markers (CD45 and CD34) Dotted line is the
isotypic control. All cell lines were tested with similar results.
doi:10.1371/journal.pone.0028175.g001
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mesenchymal lineages, BM-MSCs efficiently underwent osteogen-
ic, adipogenic and chondrogenic differentiation, whereas HI-
MSCs efficiently only underwent osteogenic and chondrogenic
differentiation (Figure 2). Adipogenic differentiation of HI-MSCs
was only observed in rare cells containing lipid droplets.
Effect of culture media in stem cell morphology
To investigate the effect on morphology by the differentiative
medium, stem cells from different origins -HI-MSCs and BM-
MSCs- were cultured with basal medium supplemented with
platelet lysate (PL), retinoic acid, activin, GLPI-1, EGF, FGF,
beta-cellulin, nicotinamide and glutamine. In this way differenti-
ation of ILCs was induced for 3 weeks. In Figure 3 the
undifferentiated MSCs assumed an adherent spindle, fibroblast-
like cell morphology (A); they then differentiated to organize small
aggregates (B) which led to maturation in islet-like cells (C).
Ultrastructural analysis showed that undifferentiated MSCs are
characterized by stem cells featuring a ribosome-rich undifferen-
tiated cytoplasm and a bean-shaped nucleus (D); BM-MSC
differentiated cells disclose numerous RER cisternae associated
with some electron-dense core insulin-like granules (E); and finally,
HI-MSC differentiated cells revealed a few secretory granules with
a central electron-dense core and a peripheral halo resembling
immature insulin-secreting granules (F). In Figure 4, cytofluori-
metric analysis in HI-MSC differentiated cells showed the
expression of ILC islet markers such as insulin, C-peptide, PDX-
1 and Glut-2 (panel A); in BM-MSC differentiated cells only Glut-
2 and insulin were expressed (panel B). Immunofluorescence on
coverslips confirms that HI-ILC expressed insulin and PDX-1
(data not shown). ELISA tests on supernatants after 25 mM
glucose stimulation (Figure 4 panel C) detected a robust secretion
by HI-ILCs and an evident secretion by BM-ILCs. Both results are
in the reference range for values from serum of healthy human
donors (11–86 pmol/L – confidence interval 95% -). HI-ILCs
showed almost a three-fold increase in insulin concentration in
comparison to BM-ILCs (30 pmol for HI-ILCs versus 11 pmol for
BM-ILCs). No detectable levels were found in HI-MSC and BM-
MSC (insulin values below the detection limit of 3 pmol). Data
suggest that the obtained ILCs represent a definitive step towards
committed b-like cells sensitive to glucose challenge.
Proteomics
Proteins from three independent biological replicas of MSCs
and ILCs were extracted and analyzed by 2-DE using a nonlinear
gradient of pH 3–10. Resulting gels, stained with Colloidal
Coomassie blue G, were quantitatively and statistically analyzed
by PDQuest as described above (see Material and Methods).
Figure 5 shows representative 2-DE gel images, showing the
differentially expressed spots identified in each gel, illustrated by
different colors. Overall, we selected spots that were shared or
unique in each cell line, and these were excised from gels and
subjected to in-gel tryptic digestion and identification by MALDI-
TOF, for a total of 315 spots. These proteins corresponded to 72
unique proteins, and in some case the same protein was identified
in different spots over the gel (e.g. GRP78 or PDIA1 in Fig. 5).
Among these 72 proteins, listed in Tables 1, 2, and 3, eleven
proteins (indicated in black in Fig. 5 A–B–C–D) were shared by all
cell lines. After statistical analysis of the normalized quantities of
matched spots of 2-DE of these shared proteins, only six proteins
Figure 2. Multilineage differentiation of BM and HI-MSCs. (A) cultured BM-MSCs and (B) HI-MSCs before differentiation. (C–D) Representative
micrographs of osteogenic differentiation: calcium depositions were detected by Alizarin Red after culturing BM-MSCs (C) and HI-MSCs (D) for 21
days in specific osteogenic medium (see Material and Methods). (E–F) Representative micrographs of adipogenic differentiation showing the
presence of lipid droplets after 21 days in adipogenic differentiating medium in of BM-MSCs (E) and HI-MSCs (F) respectively. (magnification 6200).
(G and H) Representative micrographs of chondrogenic differentiation shown by formation of a pellet positive for safranin O (G) and alcian blue (H)
after culturing HI-MSC in chondrogenic medium for 28 days (magnification 6100). Five different lines were studied with similar results.
doi:10.1371/journal.pone.0028175.g002
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significant differences (Table 1). Comparison between gels
revealed evident differences in the qualitative and quantitative
proteomic profile between the two populations of MSCs basal lines
(panel A and C and Table 2). As shown in Figure 5 (panel C), there
were 25 most expressed proteins in HI-MSCs; only four of these
were shared with BM-MSCs (LMNA, TPM4, HSPB1, YBOX,
indicated in blue), and ten were unique for these basal cells
(indicated in yellow). Out of the forty proteins visualized in the
BM-MSCs gel (panel A), twenty-four were unique for this basal
cell population (indicated in green). This was more than twice the
number found in HI-MSCs, probably due to a major undifferen-
tiated state of the BM-MSCs compared to a partial committed
state of basal HI-MSCs. After the ILCs differentiation (panel B
and D and Table 3) with the identical conditioning process, a
different repertoire of proteins was generated. Both types of ILCs
were characterized by three new proteins, APOA1, ATL2 and
SODM (indicated in red), while some remained unique to the
individual differentiated cells lines. APOA1 was more greatly
expressed in HI-ILCs compared to BM-ILCs, a difference that was
statistically significant. In particular, new proteins were expressed:
fourteen proteins (indicated in light blue) unique to BM-ILCs, and
six unique to HI-ILCs (indicated in violet). 2-DE Western blotting
for Insulin detected the hormone in both cell populations,
confirming the immunological data. Figure 5 (panel E) shows that
insulin expression was higher in HI-MSC differentiated cells
compared to the BM counterpart.
The comparison of our data with the proteomic reference map
of human islet cells [6] is only tentative as different cell lines are
present in pancreatic islets.
Nevertheless, several of the proteins identified in HI-ILCs are in
accordance with the islet reported data (GAPD, GRP78, HSP 60
ATP beta chain, PDI, Calreticulin and ACTB), while others
present in the basal MSCs (like Elongation factor 1, HSP 70 and
a-enolase) are lost following induction of differentiation. Other
proteins are expressed by conditioned cells and are not found in
islet cells. However, a more stringent comparison is hampered by
the fact that islet cells from the human pancreas are a composite
population of different endocrine cells and not only beta-cells.
Hierarchical Cluster analysis
The expression profiling of the identified proteins (reported in
the heat map in Fig. 6), underlines the groups of proteins uniquely
expressed by the four cell types, as well as those expressed by both
stem cell lines or both differentiated cell lines, or all the different
cell types. The hierarchical cluster also reveals a marked difference
between the proteins expressed by the basal cell lines and the
differentiated ones. As indicated by the tree (Figure 6), the two cell
lines lie on two separated branches, demonstrating that their
expression profiles are dissimilar.
Figure 3. Morphological changes and ultrastructural analysis of BM and HI-MSCs during differentiation. (A) Representative HI-MSCs
undifferentiated cells shows a fibroblast-like cell morphology (B) after 7 days in the complete differentiative medium HI-MSCs started to organize into
small aggregates (C) finally, during maturation, HI-ILCs formed islet-like spatial structures. Electron microscopy:( D) HI-MSCs before differentiation
showed stem cell features with undifferentiated cytoplasm and bean-shaped nucleus, (E) High magnification of a cytoplasm from a BM-ILCs derived
cell showing numerous RER cisternae associated with some electron-dense core insulin-like granules. (F) HI- ILCs shows few secretory granules with a
central electron-dense core and a peripheral halo resembling immature insulin-secreting granules.
doi:10.1371/journal.pone.0028175.g003
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In the effort of making SC of different origins suitable for
clinical use in human patients, the key role of four genes (OCT4
KLF4 SOX2 and c-Myc) emerged as an effective approach to
increasing pluripotency through reprogramming [16,17]. A recent
report described the induction of MSCs from renal mesangial cells
by transfection for these factors [18].
While the reprogramming of MSCs is emerging as a pivotal
element, several divergent strategies were developed to limit or
avoid harsh manipulations that, although effective, may be prone
to side effects, hampering the safety of such interventions.
An innovative approach was utilized by a recent report [19].
The described results rely upon the recognition of the constitu-
tional activation of one or more of the above factors in skin-
derived SC from the dermal papilla of hair follicles.
Several different strategies and innovative ways were put
forward to induce less drastic cellular modifications, based on
limited genetic manipulation and controlled expression of
transforming factors, [20] such as the use of micro RNAs, and
small molecules acting as stimulators or inhibitors of definite
signaling pathways that may open new effective approaches [21].
Theinductiverole ofthemicroenviromentmayalsobeimportant
in order to achieve maturation to functional beta cells, and may
possibly be fully exploited in vivo. Interestingly, in the recent report
by Karniel, BM-MSC transfected with rat PDX1 produced insulin
in vitro, and showed transcription of human PDX1 when
transplanted in kidney capsules of immunodeficient mice [22].
Figure 4. Analysis of Islet expression by Flow cytometry and measurement of insulin secretion by ELISA. (A) Representative FACS
analyses shows that HI-MSCs were positive for markers characteristic of ILCs (Insulin, PDX-1, C-peptide and Glut-2) and that (B) BM-MSCs were only
positive for Glut-2; (C) ELISA test shows insulin levels of supernatants from MSCs at basal level (BM-MSCs and HI-MSCs) and after differentiation to
ILCs (BM-ILCs and HI-ILCs).
doi:10.1371/journal.pone.0028175.g004
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Insulin. Representative image from three independent experiments of Coomassie blue stained 2-DE patterns of (A) BM-MSCs, (B) BM-ILCs, (C) HI-
MSCs and (D) HI-ILCs. Proteins showing differential expression were indicated with different colours: in black -proteins identified in all cell lines-; in
blue- proteins identified in basal cell lines; in yellow- proteins identified only in HI-MSCs; in green- proteins identified only in BM-MSCs; in red- proteins
identified in ILCs obtained from HI-MSCs and BM-MSCs, in violet proteins identified only in HI-ILCs; in light blue- proteins identified only in BM-ILCs.
Corresponding identifications are reported in Tables 1, 2, 3. In (E) Representative image of 2-DE Western blotting for Insulin detected in BM-ILCs and
HI-ILCs.
doi:10.1371/journal.pone.0028175.g005
Table 1. Proteins shared by MSCs and ILCs, as identified by MALDI-TOF MS.
Proteins identified in all cell populations (HI-MSCs; BM-MSCs, HI-ILCs, BM-ILCs)
Acc.Numb Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
O43852 CALU Calumenin 37198 4,47 7 28 70 1,160,5 S*
P27797 CALR Calreticulin 48283 4,29 10 32 114 1,560,3 S*
P10809 CH60 60 kDa heat shock protein,
mitochondrial
61187 5,7 9 21 80 1,760,6 NS
P11021 GPR78 78 kDa glucose-regulated protein 72402 5,07 16 35 185 3,760,1 HS**
P07237 PDIA1 Protein disulfide-isomerase 57480 4,76 10 27 111 2,560,3 S*
P30101 PDIA3 Protein disulfide-isomerase A3 57146 5,98 11 29 124 2,161,7 NS
Q96HG5 ACTB Actin, cytoplasmic 1 42052 5,29 13 38 149 3,160,2 S*
P63261 ACTG Actin, cytoplasmic 2 42108 5,31 13 38 149 3,160,2 S*
P04406 G3P Glyceraldehyde-3-phosphate
dehydrogenase
36201 8,57 6 27 63 1,161,6 NS
P60174 TIPS Triosephosphate isomerase 26938 6,45 15 67 233 0,760,5 NS
Q96ML2 VIM Vimentin 53676 5.06 19 45 210 2,161,1 NS
aMW, molecular weight.
bpI, isoelectric point.
cNumber of matched mass values on number of total mass values searched.
dThe sequence coverage, which is calculated as the percentage of identified sequence to the complete sequence of the matched protein.
eMascot Score.
fRatio between level of spot avarage expression indicated in Fig. 5 Standard deviation is indicated. For the significance two-sided Student’s t test was used
(*p,0.05,**p,0.01).
doi:10.1371/journal.pone.0028175.t001
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Proteins identified in basal cell populations (HI-MSCs;BM-MSCs)
Acc.Numb Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
Q9UC36 HSPB1 Heat shock protein beta-1 22826 5,98 8 42 121 1,360,9 NS
P02545 LMNA Prelamin-A/C 74380 6,57 17 27 170 2,161,3 NS
Q9UCS3 TPM4 Tropomyosin alpha-4 chain 28619 4,67 8 31 91 1,560,9 NS
P67809 YBOX Nuclease-sensitive
element-binding protein 1
35903 9,87 8 19 65 0,960,8 NS
Proteins identified only in HI-MSCs
Acc.Numb Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
P12814 ACTN1 Alpha-actinin-1 103563 5,25 10 13 72 _ _
O43707 ACTN4 Alpha-actinin-4 105245 5,27 12 16 98 _ _
Q9UPY3 DICER Endoribonuclease Dicer 221279 5.47 12 20 56 _ _
P30040 ER29 Endoplasmic reticulum
resident protein 29
29032 6,77 6 28 67 _ _
Q96AY3 FKB10 Peptidyl-prolyl cis-trans
isomerase FKBP10
64717 5,36 8 17 78 _ _
P11142 HSP7C Heat shock cognate 71 kDa protein 71082 5,37 8 17 103 _ _
Q13162 PRDX4 Peroxiredoxin-4 30749 5,86 8 43 94 _ _
P36873 PP1G Serine/threonine-protein
phosphatase PP1-gamma
catalytic subunit
37701 6,12 7 27 72 _ _
Q9NRP7 STK36 Serine/threonine-protein kinase 36 143995 5.57 8 20 53 _ _
Q6J9G0 STYK1 Tyrosine-protein kinase STYK1 47576 7.10 8 15 40 _ _
Proteins identified only in BM-MSCs
Acc.Num Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
Q96L71 ARAP1 Arf-GAP with Rho-GAP domain, 163743 5,86 9 10 68 _ _
O95816 BAG-2 BAG family molecular chaperone
regulator 2
23928 6,25 7 32 72 _ _
Q05682 CALD1 Caldesmon 93251 5,63 8 12 57 _ _
Q8N8E3 CCD46 Coiled-coil domain-containing
protein 46
113192 6,25 9 11 56 _ _
P42771 CD2A1 Cyclin-dependent kinase
inhibitor 2A, isoforms 1/2/3
16579 5,52 4 28 60 _ _
P02511 CRYAB Alpha-crystallin B chain 20146 6,76 9 45 140 _ _
P29692 EF1D Elongation factor 1-delta 31217 4,9 9 37 104 _ _
Q6GMP2 ENOA Alpha-enolase 47481 7,01 11 39 151 _ _
Q8IWF6 FF116A Protein FAM116A 70215 8,52 6 13 59 _ _
P50851 LRBA Lipopolysaccharide-responsive
and beige-like anchor protein
321586 5,39 14 7 68 _ _
Q9UPN3 MACF1 Microtubule-actin cross-linking
factor 1, isoforms 1/2/3/5
623626 5,27 16 3 56 _ _
Q99707 METH Methionine synthase 141749 5,39 9 9 56 _ _
Q9Y623 MYH4 Myosin-4 223902 5,65 11 7 56 _ _
Q99497 PARK7 Protein DJ-1 20050 6,33 7 28 70 _ _
Q9NVY1 PCID2 PCI domain-containing protein 2 46627 8,78 5 12 56 _ _
P00558 PGK1 Phosphoglycerate kinase 1 44985 8,3 7 18 70 _ _
P37837 TALDO Transaldolase 37688 6,36 6 24 57 _ _
Q9NVG8 TBC13 TBC1 domain family member 13 47151 5,11 5 19 59 _ _
P09936 UCHL1 Ubiquitin carboxyl-terminal
hydrolase isozyme L1
25151 5,33 6 31 67 _ _
Q6ZS46 YF009 Putative uncharacterized protein
FLJ45840
22478 10,58 5 34 63 _ _
P82664 RT10 28S ribosomal protein S10,
mitochondrial
23099 7,78 6 32 63 _ _
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limitations. Nevertheless, a more detailed description of protein
modifications induced only by culture media conditioning may
constitute the basis for a rational and safe manipulation of stem
cells derived from different sources.
The search for small molecules that interfere with signalling
pathways may open new useful opportunities for clinical usage in
several human disease conditions.
Our study was aimed to clarify modification of MSCs of
different origin towards pancreatic beta cell differentiation via
culture media induction of differentiation.
Modification of the protein asset during these medium-induced
modifications may be of interest in order to correlate the
regulatory mechanisms acting in the differentiation process.
Moreover, it may possibly give an insight into the medium-
induced SCs modifications that would be useful for a better control
of cell manipulations through safe and conservative approaches.
Proteomic analysis enhanced the differences in the MSCs
related to the site of origin, reflecting spontaneous differentiation
and commitment.
The conditioning media produced modifications of protein
expression in both basal MSCs, with partially similar results, and a
reductioninthenumberofproteinsexpressed.Itisnotsurprising that
2-DE analysis failed to detect Insulin, probably due to its low
molecular weight (5808 Da) which has also been reported in the
literature [9]. Insulin was however, detectable in 2-DE Western
blottingfromcellpopulationsafterdifferentiation,andinsupernatants
of ILCs after glucose stimulation, as demonstrated by ELISA analysis.
A limited number of proteins were present in ILCs with b
phenotype, and the original controls were PDIA1, PDIA3,
GPR78, vimentin, CH60 and triphosphates isomerase. The
differentiated cells maintained a proteomic profile restricted to
the cell type of origin, and expressed a specific set of new proteins.
Three new proteins, APOA1, ATL2 and SODM (indicated in
red), were present in both ILC types.
APO A1 is a protein involved in lipid transport and metabolism;
it is also a constituent of the cell membrane, and it may have a
critical role in beta cells in the regulation of lipid metabolism in
tapering fatty acid toxicity towards islet beta-cells [23]. In addition
it has been related to chronic glucose stimulation, as seen in an
insulinoma cell model, and in diabetes type II [24].
The role of ATL 2 may be relevant as it belongs to a class of
proteins mediators of homotypic fusion of endoplasmic reticulum
membranes [25], and the absence of ATL 1 is involved in the
pathogenesis of hereditary spastic paralysis [26].
SODM (mitochondrial superoxide dismutase) is an essential
component of the cellular defense mechanism against oxidative
stress (ROS), which contributes to the damage to beta cells that
plays a role in the pathogenesis of type 2 diabetes [27].
Besides the morphological similarity with the formation of an
‘‘islet-like’’ growth pattern induced by conditioning media,
relevant differences of the proteomic asset were still present and,
more importantly, while HI-MSCs were induced to secrete insulin
and to produce evident secretory granules, conditioned cells
derived from BM-MSCs produced only small quantities of insulin
and, although formed islet-like agglomerates, maintained a more
undifferentiated phenotype, as also determined by transmission
electron microscopy.
The conditioning approach, so far, is effective in inducing
insulin production by HI-MSCs, and further improvements may
be forecast in this direction [22]. As enhanced by hierarchical
cluster analysis and well-depicted in the heat map, culture
conditioning was able to modify the protein asset of both basal
cell lines, but towards apparently divergent differentiation
pathways. This phenomenon may underscore the actual limits of
a culture conditioning approach that may stimulate some degree
of differentiation, but not change the direction of this process.
However rational manipulation of culture conditions and the quest
for possible inducing molecules might open new perspectives for
the use of MSC from easily accessible sources for clinical usage in
human pathology.
Materials and Methods
Chemicals and reagents
Liver Digest Medium was purchased from Gibco. Minimum
essential medium/endothelial cell basal medium-1 (a-MEM/
EBM), Alizarin Red, Transforming Growth Factor b3w e r e
purchased from Lonza (Basel, Switzerland). Streptomycin,
penicillin, protease inhibitors,b e n z o n a s e ,a m m o n i u mp e r s u l f a t e
(APS), bromophenol blue, glycerol, N,N,N9,N9-tetramethylethy-
lene-diamine (TEMED), sodium dodecyl sulphate (SDS),
TRIZMA, urea, 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulphonate (CHAPS), dithiothreitol (DTT), iodoaceta-
mide, Oil Red O, safranin O, alcian blue, nicotinammide, were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Activin,
Glucagon-like peptide I (GLPI-1), Epidermal growth factor
(EGF), Fibroblast growth factor (FGF), Beta-cellulin were
purchased from PeproTech Inc.( Rocky Hill, NJ) DC Protein
assay kit, acrylamide, agarose, ready-made immobilized pH
Proteins identified only in BM-MSCs
Acc.Num Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
O60664 PLIN3 Perilipin-3 47189 5,3 7 23 82 _ _
Q13561 DCTN2 Dynactin subunit 2 44318 5,1 6 18 52 _ _
P10073 ZSC22 Zinc finger and SCAN domain-
containing protein 22
55724 7,36 6 18 64 _ _
aMW, molecular weight.
bpI, isoelectric point.
cNumber of matched mass values on number of total mass values searched.
dThe sequence coverage, which is calculated as the percentage of identified sequence to the complete sequence of the matched protein.
eMascot Score.
fRatio between level of spot avarage expression indicated in Fig. 5 Standard deviation is indicated. For the significance two-sided Student’s t test was used
(*p,0.05,**p,0.01).
doi:10.1371/journal.pone.0028175.t002
Table 2. Cont.
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were purchased from Bio-Rad (Hercules, CA, USA). Ampho-
line pH 3.5–10 and 5–8 were obtained from GE Healthcare
(MI, ITALY). Fetal bovine serum, DMEM-low glucose,
glutamine, Adipogenic, Osteogenic and Chondrogenic differ-
entiation kits, EuroMed Human Mesenchymal Stem Cell Kit,
nitrocellulose membrane, enhanced chemiluminescence kit
were purchased from EuroClone (MI, ITALY). All phycoery-
thrin (PE) or fluorescein isothiocyanate (FITC) conjugated anti-
CD105, -CD29, CD14, -CD31, -CD146, -CD44, -CD90
(Dakocytomation, Copenhagen, Denmark); -CD73, -CD34, -
CD45, -CD80, -CD86,-CD166, HLA-I (Becton Dickinson
Biosciences Pharmingen, San Jose, CA); -CD133 (Miltenyi
Biotec, Auburn); KDR (R&D Systems, Abington, U.K.); -HLA-
II (Chemicon International Temecula, CA), -CD40 (Immuno-
tech, Beckman Coulter), -CD154 (Serotec, Raleigh, NC USA);
Insulin, PDX1, GLUT-2, and secondary antibodies Anti-Rabbit
IgG Alexa Fluor 488 conjugate, Anti-Mouse IgG Alexa Fluor
488 conjugate were purchased from Cell Signalling Technol-
ogy, Inc. (Danver, MA).
Table 3. Proteins differentially expressed in ILCs as identified by MALDI-TOF MS.
Proteins identified in ILCs obtained from HI-MSCs and BM-MSCs with conditioned media
Acc.Numb Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
P02647 APOA1 Apolipoprotein A-I 30759 5,56 12 37 147 3,260,1 HS**
P04179 SODM Superoxide dismutase [Mn],
mitochondrial
24878 8,35 6 30 72 1,160,8 NS
Q8IUZ5 AT2L2 Alanine–glyoxylate aminotransferase
2-like
50135 6,28 7 18 68 2,160,9 NS
Proteins identified only in HI-ILCs
Acc.Num Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
P04004 VTNC Vitronectin 55069 5,55 8 16 76 _ _
P21796 VDCA Voltage-dependent
anion-selective channel protein 1
30868 8,62 6 31 110 _ _
P06727 APO4A Apolipoprotein A-IV 45371 5,28 12 29 21 _ _
P10909 CLUS Clusterin 53031 5,89 7 22 76 _ _
P35232 PHB Prohibitin 29843 5,57 6 27–34 102 _ _
P06576 ATPB ATP synthase subunit
beta, mitochondrial
56525 5,26 10 29 109 _ _
Proteins identified only in BM-ILCs
Acc.Num Ab.Name Full Name MW(Da)
a pI
b MP
c C%
d MS
e Ratio
f p
Q96MZ4 CB039 Uncharacterized protein C4orf39 17295 11,82 5 53 64 _ _
P30084 ECHM Enoyl-CoA hydratase,
mitochondrial
31823 8,34 5 25 59 _ _
Q9UC56 GPR75 Stress-70 protein, mitochondrial 73920 5,87 8 16 68 _ _
Q0VDF9 HSP7E Heat shock 70 kDa protein 14 55444 5,41 7 19 65 _ _
P17612 KAPAC cAMP-dependent protein
kinase catalytic subunit alpha
40678 8,84 6 19 58 _ _
P33176 KINH Kinesin-1 heavy chain 110358 6,12 8 11 56 _ _
Q9BXS6 NUSAP Nucleolar and
spindle-associated protein 1
49593 9,92 5 16–28 60 _ _
Q9H165 BC11A B-cell lymphoma/leukemia 11A 92565 6,15 8 11 56 _ _
Q6NV74 CB055 Uncharacterized protein C2orf55 102665 8,13 6 10 56 _ _
Q8IYJ1 CPNE9 Copine-9 62281 5,18 7 16 59 _ _
Q8N0V1 Cu121 Putative uncharacterized
protein C21orf121
14961 9.08 3 31 47 _ _
Q9Y2A4 ZN443 Zinc finger protein 443 80145 9.30 7 12 60 _ _
Q9P249 SEM6D Semaphorin-6D 121050 8,77 8 9 56 _ _
Q9Y4L1 HYOU1 Hypoxia up-regulated protein 1 111494 5,16 7 8 56 _ _
aMW, molecular weight.
bpI, isoelectric point.
cNumber of matched mass values on number of total mass values searched.
dThe sequence coverage, which is calculated as the percentage of identified sequence to the complete sequence of the matched protein.
eMascot Score.
fRatio between level of spot avarage expression indicated in Fig. 5 Standard deviation is indicated. For the significance two-sided Student’s t test was used
(*p,0.05,**p.0.01).
doi:10.1371/journal.pone.0028175.t003
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and Islet-derived Mesenchymal Stromal Cells (BM-MSCs
and HI-MSCs)
Approval of the study was obtained from the Center for
Molecular Biotechnology Institutional Review Board. BM-MSCs
were obtained from Lonza (Basel, Switzerland), cultured and
characterized as previously described [15]. In brief, to expand the
bone marrow cells, the adherent monolayer was detached by
trypsin treatment for 5 minutes at 37uC, after 15 days for the first
phase and every 7 days for each successive step. Cells were seeded
at a density of 10,000 cells/cm
2 and used during passage six. At
each passage, cells were counted and analyzed for immunophe-
notype by cytofluorimetric analysis.
HI-MSCs, human pancreatic islets were obtained from the
laboratory of islet transplantation (San Giovanni Battista Molin-
ette Hospital, Torino). All tissue donors gave written, informed
consent (according to procedures approved by Ethical Committee
of San Giovanni Battista Hospital) for use of tissues for scientific
research. Islets were purified according to Ricordi’s protocol [2]
from pancreases discarded for transplantation, and digested by
treatment for 15 minutes at 37uC with Liver Digest Medium. The
obtained suspension was then collected at the bottom of a conical
tube by spontaneous precipitation, and the digested islets were
transferred to fibronectin-coated T25 flasks in the presence of
Minimum essential medium/endothelial cell basal medium-1 (a-
MEM/EBM) (3:1) supplemented with penicillin (50 IU/ml),
streptomycin (50 mg/ml) and 10% of Foetal Calf Serum. Within
4 days, an islet outgrowth of adherent, monomorphic and spindle-
shaped cells was observed. Confluence was achieved by day 7–8
when the cell monolayer was detached by trypsin–EDTA
treatment. The remnants of the islets were removed by low-speed
centrifugation and cells were expanded in the same medium at a
concentration of 10,000 cells/cm
2. At each passage, cells were
counted and analyzed for immunophenotype by cytofluorimetric
analysis.
The adipogenic, osteogenic and chondrogenic differentiation
ability of BM and HI-MSCs was determined as previously
described [14]. Briefly, BM-MSC and HI-MSCs were cultured
with an Adipogenic differentiation kit for 3 weeks. To evaluate
differentiation, cells were fixed with 4% paraformaldehyde for
20 minutes at room temperature, and stained with 0.5% Oil Red
O in methanol for 20 minutes at room temperature.
Osteogenic differentiation was assessed by culturing BM-MSCs
and HI-MSCs using an Osteogenic differentiation kit. Medium
was changed 2 times a week, for 3 weeks. To evaluate
differentiation, cells were fixed with 4% paraformaldehyde for
20 minutes and stained with Alizarin Red, pH 4.1 for 20 minutes
at room temperature.
MSCs differentiation
For chondrogenic differentiation, 2.5610
5 HI-MSCs and BM-
MSCs were centrifuged in a 15-ml conical polypropylene tube
(Falcon BD Bioscience) at 150 g for 5 minutes and washed twice
with DMEM. BM-MSCs and HI-MSCs pellets were cultured
using a Chondrogenic differentiation kit supplemented with
10 ng/ml of Transforming Growth Factor b3. Medium was
changed every 3 days for 28 days. Pellets were fixed in 4%
paraformaldehyde overnight, and paraffin-embedded sections
were stained for glycosaminoglycans using 0.1% safranin O and
for sulfated proteoglycans with 1% alcian blue.
Flow Cytometry
The following antibodies, all phycoerythrin (PE) or fluorescein
isothiocyanate (FITC) conjugated, were used for cytofluorimetric
analyses: anti-CD105, -CD29, CD14, -CD31, -CD146, -CD44, -
CD90, -CD73, -CD34, -CD45, -CD80, -CD86,-CD166, HLA-I, -
CD133; KDR, -HLA-II, -CD40, -CD154 monoclonal antibodies.
Mouse IgG isotypic controls were from Dakocytomation.
The following panel of Alexia Fluor conjugated antibodies was
used: Insulin, PDX1, GLUT-2. Conjugated antibodies were
incubated for 4 minutes in phosphate buffer saline (PBS) with
0.1% of Triton X 100. For each determination at least 10,000 cells
were analyzed on a FACSCALIBUR cytometer (BD). Cell Quest
(BD) software was used for result evaluation, including dot-plot
and percentage of positive cells.
Procedure to differentiate the MSCs populations into
ILCs
HI-MSCs and BM-MSCs were cultured by seeding 1610
5 cells
in T75 flasks using a EuroMed Human Mesenchymal Stem Cell
Kit and grown at 80% of confluence, then differentiated towards
b-cells like cells with the following medium: DMEM-low glucose,
Platelet Lysate (PL) 5%, retinoic acid 10 mM (for 24 hours only),
Activin 10 mg/ml, Glucagon-like peptide I 200 mg/ml (GLPI-1),
Epidermal growth factor 20 ng/ml (EGF), Fibroblast growth
factor 10 ng/ml (FGF), Beta-cellulin 10 mg/ml, nicotinammide
10 mM/L, glutamine 2 mM.
Cultures were using adherent conditions for the first 7 days then
changed to ultra low attachment dishes (Corning) for a further 2
weeks.
Immunofluorescence
Indirect immunofluorescence was performed on differentiated
cells after 2% paraformaldehyde fixation. Cells were permeabi-
lized with methanol (MetOH) for some antigens.
Primary antibodies were diluted according to manufacturer’s
instructions. The following antisera were utilized: pancreatic
duodenal homeobox gene-1 (PDX1), Insulin, C Peptide. Second-
ary antibodies were Anti-Rabbit IgG Alexa Fluor 488 conjugate,
Anti-Mouse IgG Alexa Fluor 488 conjugate. Non-immune rabbit
or mouse sera were used as negative controls at a 1:50 dilution.
Ultrastructural analysis
HI-MSCs and BM-MSCs were fixed in 2.5% sodium
cacodylate-buffered glutaraldehyde immediately after in vitro
differentiation. Pelleted cells were post-fixed in osmium tetroxide
in the same buffer, dehydrated in ethanol and embedded in
Araldite. Thin sections stained with uranyl acetate and lead citrate
were studied in a Philips 400T transmission electron microscope.
Insulin secretion by ELISA
Supernatants from MSCs (HI-MSCs and BM-MSCs) and ILCs
(HI-ILCs and BM-ILCs) at standard culture conditions (i.e. prior
to glucose challenge) and after stimulation with 25 mmol/l glucose
for 2 hours were collected and frozen at 280uC. A non-
conditioned medium was used as a negative control for secreted
Figure 6. Hierarchical Cluster Analysis. This figure shows a cluster map of the proteins expressed in the different cell lines. The tree on the left
represents the hierarchical cluster analysis on the 72 proteins. In the heat map, black squares show the expression of the corresponding protein in the
correspondent cell lines, while white squares show no expression.
doi:10.1371/journal.pone.0028175.g006
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ELISA kit (Dako, Italy) according to the manufacturer’s
instructions.
Sample preparation for proteomics
HI-MSCs and BM-MSCs cell lines, control and differentiated
cells, were collected directly from flasks and washed twice in PBS.
Cells lysates were obtained using 2DE lysis solution (8 M urea, 4%
w/v CHAPS, 40 mM Tris) with added protease inhibitor and
benzonase (Sigma) by gentle lysis methods (freeze-thaw lysis) and
shaking for 24 hours at room temperature.
Suspensions were centrifuged at 12,000 rpm for 15 min at 4uC,
and the supernatants were conserved for 2-DE analysis. Protein
concentrations were measured using a DC Protein Assay Kit.
2-DE electrophoresis analysis
The 7 cm ready-made IPG strips, pH 3–10 NL, were
rehydrated in the passive mode with a 125 ml total volume
contains 150 mg of protein, 2.5% (v/v) ampholine (3–10) and
1%(w/v) DTT. Western blotting for Insulin was performed with
300 ug of protein in the 7 cm ready-made IPG strips, pH 4–7.
Isoelectric focusing was carried out in a Protean IEF cell apparatus
(Bio-Rad).
In brief, focusing for the 7 cm IPG strips was started at 250 V;
voltage was progressively increased up to 4000 V until a
maximum of 25000 V-h was reached. Focusing was performed
at 18uC with a limit of 50 mA per strip. Once the first dimension
separation was terminated, the strip was equilibrated in two steps.
The first with 50 mM Tris-HCl, pH 8.8, Urea 6 M, Glycerol 30%
(v/v), SDS 2% (w/v) and DTT 1% (w/v) for 15 minutes, and the
second step with the same buffer and the same time but with 2.5%
(w/v) iodoacetamide instead of DTT.
For the second dimension separation, 10% vertical SDS-
polyacrylamide gels were used.
Gels were stained with colloidal Coomassie Blue (18% v/v
ethanol, 15% w/v ammonium sulphate, 2% v/v phosphoric acid,
0.2% w/v Coomassie G-250) for 48 hours, destained with water,
and scanned using PDQuest software (version 7.2, Bio-Rad); all
spots were processed for matrix-assisted laser desorption/ioniza-
tion mass spectrometry (MALDI-TOF) analysis.
2-DE Western blotting
The small format gel was transferred to a nitrocellulose
membrane. Membranes were blocked with 3% w/v BSA in
PBS/Tween 20 0.1% (v/v) for 1 hour; membranes were then
washed three times with PBS and probed with a 1:200 dilution of
anti-Insulin antibody O.N. at 4uC. Membranes were washed six
times with PBS, incubated for 1 hour with a 1:1000 dilution of
anti-rabbit IgG peroxidase-labeled antibody and immuno-reactiv-
ity was detected with an enhanced chemiluminescence kit.
Image analysis
2-DE image analysis was performed using PD-Quest software
(Bio-Rad) according to the manufacturer’s instructions. The
normalization of each individual spot was performed according
to the total quantity of valid spots in each gel, after subtracting
background values. The spot volume was used as the analysis
parameter to quantify protein expression.
In gel Digestion and MALDI- TOF analysis
Coomassie G-stained spots were excised from 2-DE gels;
destaining and in-gel enzymatic digestion were performed as
previously described [28]. Briefly, each spot was destained with
100 ml of 50% v/v acetonitrile in 5 mM ammonium bicarbonate
and dried with 100 ml of acetonitrile. Each dried gel piece was
rehydrated for 40 minutes at 4uCi n1 0ml of a digestion buffer
containing 5 mM ammonium bicarbonate, and 10 ng/mlo f
trypsin. Digestion was allowed to proceed overnight at 37uC and
peptide mixtures were stored at 4uC until assayed. All digests
were analyzed by MALDI-TOF (TofSpec SE, MicroMass)
equipped with a delayed extraction unit. Peptide solutions were
prepared with equal volumes of saturated a-cyano-4-hydroxy-
cinnamic acid solution in 40% v/v acetonitrile-0.1% v/v
trifluoroacetic acid. The MALDI-TOF was calibrated with a
mix of PEG (PEG 1000, 2000 and 3000 with the ratio 1:1:2) and
mass spectra were acquired in the positive-ion mode. Peak lists
were generated with ProteinLynx Data Preparation (ProteinLynx
Global Server 2.2.5) using the following parameters: external
calibration with lock mass using mass 2465.1989 Da of ACTH,
background subtract type adaptive combining all scans, perform-
ing deisotoping with a threshold of 1%. The twenty-five most
intense masses were used for database searches against the
SWISSPROT database (release 2011-01 of 11-Jan-11) using the
free search program MASCOT 2.3.02 (http://www.matrixscience.
com). The following parameters were used in the searches: taxa
Homo sapiens, trypsin digest, one missed cleavage by trypsin,
carbamidomethylation ofcysteine as fixed modification,methionine
oxidation as variable modification and maximum error allowed
100 ppm. Only proteins with a Mascot score .55 were taken into
consideration.
Statistical analysis
Data from image analysis were used as values of protein
expression in 2-DE experiments as previously described [29]. The
two-tailed Student’s t test was used to verify the significance of the
variations of expression of proteins in HI-MSCs and BM-MSCs
cells, control and differentiated cells. Experiments were per-
formed in triplicate. Statistical significance was set at p-
values#0.05 (Tables 1, 2, 3). In 2-DE experiments proteins were
classified as differentially expressed if the ratio of the spot
intensity between treated cells and control cells was greater than
1.5-fold (protein overexpressed) or lower than 0.5-fold (protein
underexpressed). For proteins expressed by all cell populations
the ratio is calculated between value of the basal cells (HI-MSCs,
BM-MSCs) compared to the mean value of differentiated cells
(HI-ILCs, BM-ILCs).
Hierarchical Cluster Analysis
The expression profile of the identified proteins was analyzed
with hierarchical cluster analysis to underline similarities between
proteins as previously described [30]. The analysis was performed
with R software 2.11.1 [31] and the package gplots 2.8.0 [32]. The
distance matrix was obtained with the Euclidean method, and the
clustering with the furthest neighbour method. The heat map was
obtained with the default options contained in the package
function and adapted to mark expressed and unexpressed proteins
with black and white.
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